R.M. Davis Inc’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,763
Closed -$353K 231
2018
Q3
$353K Sell
2,763
-52
-2% -$6.18K 0.01% 187
2018
Q2
$305K Buy
2,815
+126
+5% +$13.7K 0.01% 192
2018
Q1
$285K Buy
2,689
+26
+1% +$3.02K 0.01% 203
2017
Q4
$312K Hold
2,663
0.01% 195
2017
Q3
$303K Hold
2,663
0.01% 186
2017
Q2
$332K Hold
2,663
0.01% 177
2017
Q1
$316K Sell
2,663
-30
-1% -$3.4K 0.01% 180
2016
Q4
$270K Sell
2,693
-165
-6% -$17.7K 0.01% 191
2016
Q3
$361K Sell
2,858
-50
-2% -$6.18K 0.02% 166
2016
Q2
$340K Buy
2,908
+209
+8% +$23.7K 0.02% 169
2016
Q1
$279K Sell
2,699
-113
-4% -$10.9K 0.01% 168
2015
Q4
$280K Buy
2,812
+113
+4% +$11.1K 0.01% 170
2015
Q3
$246K Sell
2,699
-216
-7% -$21.7K 0.01% 179
2015
Q2
$309K Buy
2,915
+1,061
+57% +$117K 0.02% 161
2015
Q1
$212K Buy
+1,854
New +$212K 0.01% 182

Other funds holding ZBH

R.M. Davis Inc's ZBH Position: Q4 2018 in Review

R.M. Davis Inc sold out of Zimmer Biomet (ZBH) in Q4 2018, closing a stake of 2,763 shares — an estimated $353K sold.

R.M. Davis Inc first reported a position in ZBH in Q1 2015 and held it in 15 quarters. The position peaked at $361K in Q3 2016. 871 funds tracked by Wall St. Rank hold ZBH as of Q4 2018.

  • R.M. Davis Inc reported no remaining Zimmer Biomet position as of Q4 2018 after selling out during the quarter.
  • R.M. Davis Inc sold 2,763 Zimmer Biomet shares in Q4 2018, an estimated $353K.
  • R.M. Davis Inc first reported a position in Zimmer Biomet in Q1 2015 and held it in 15 quarters.
  • R.M. Davis Inc's Zimmer Biomet position peaked at $361K in Q3 2016.
  • 871 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2018.

Based on R.M. Davis Inc's 13F filing for Q4 2018, filed 18 Jan 2019.